Dashboard
Discussions
Watchlists
Collections
Tools
More
Events
SIGN UP
SIGN IN
ENTITY
Celltrion (068270 KP)
Watchlist
21
Analysis
Health Care
•
South Korea
Celltrion, Inc. produces and sells biosimilar products, as well as consignment processing services for other businesses.
more
Watchlist
All
Insights
Broker
Sponsored
Syndicated
Podcast
Buy side
Refresh
Focused
Suggested
bullish
•
Celltrion Inc
•
20 May 2022 14:05
FnGuide Top 10 Rebalancing on June 10: More Substantial Flow Impact than Last Time
This post looks at the current status of the FnGuide Top 10 Index rebalancing as we are halfway through the completion of the review period.
Sanghyun Park
Follow
520 Views
Share
bearish
•
Celltrion Inc
•
14 May 2022 18:20
Celltrion (068270 KS): Muted Q1 2022 Performance Reflects Continuing Biosimilars Pricing Pressure
Celltrion reported weak Q1 results, with its operating and net profit declining y/y as well as q/q. Biosimilar selling price continues to erode due...
Tina Banerjee
Follow
384 Views
Share
bullish
•
Shinhan Financial
•
25 Apr 2022 20:13
FnGuide Top 10 (TIGER ETF) Rebalancing Preview: Shinhan Financial IN & Celltrion OUT
This post previews the semi-annual rebalancing of the FnGuide Top 10 Theme Index (TIGER ETF), which will occur on June 10.
Sanghyun Park
Follow
343 Views
Share
bullish
•
JD.com Inc (ADR)
•
27 Mar 2022 07:49
ECM Weekly (27th Mar 2022) - JD, Tencent, Prosus, Ferretti, Recbio, Nomura, Navi, Samsung, Celltrion
Aequitas Research puts out a weekly update on the deals that were covered by the team recently along with updates for upcoming IPOs.
Sumeet Singh
Follow
374 Views
Share
bullish
•
Celltrion Inc
•
21 Mar 2022 23:02
Block Deal Sale of Celltrion & Celltrion Healthcare by ION Investment
It was announced that ION Investment will partially sell its stakes in Celltrion and Celltrion Healthcare for about 560 billion won in a block...
Douglas Kim
Follow
374 Views
Share
First
Previous
31
32
33
34
35
36
37
Next
Last
Copyright © 2022 Smartkarma Innovations Pte Ltd. All Rights Reserved. v3.34.5
x